Purchases and Sales Made in Q3 2022 in Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT) during Q3 2022. The information is specifically focused on institutions that hold shares of Nuvectis Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Sabby Management, LLC
Upper Saddle River, NJ |
BUY
|
- |
633KNew |
$4.49M - $8.23M
|
633K
$2.98M
|
|
|
Nov 04, 2022
Q3 2022
|
Ronit Capital LLP
|
BUY
|
- |
143K+ 34.17% |
$1.02M - $1.86M
|
563K
$2.64M
|
|
|
Oct 14, 2022
Q3 2022
|
Baldwin Brothers LLC
|
BUY
|
- |
12K+ 9.92% |
$85.1K - $156K
|
133K
$625K
|
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
7.47K+ 31.18% |
$53K - $97.2K
|
31.4K
$148K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
6.81K+ 94.54% |
$48.2K - $88.5K
|
14K
$65.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
3.8K+ 16.36% |
$27K - $49.5K
|
27.1K
$127K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
2.77K+ 216.81% |
$19.7K - $36K
|
4.05K
$19K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
158+ 254.84% |
$1.12K - $2.05K
|
220
$1.03K
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
76New |
$539 - $988
|
76
$357
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
3+ 14.29% |
$21.3 - $39
|
24
$113
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
1+ 0.5% |
$7.09 - $13
|
201
$945
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|